Denmark vs France: Access to anti-retroviral drugs, female
Denmark
91.0%
in 2023
France
93.0%
in 2022
Denmark rank
25th
France rank
22nd
Access to anti-retroviral drugs, female over time
- Denmark
- France
How they compare
France currently reports 93.0% against 91.0% in Denmark, a difference of 2.0%.
Across all 23 years both countries report, France has been ahead every year.
Denmark ranks 25th and France ranks 22nd of 141 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.0% | 81.2% | 30.2% | France |
| 2010s | 77.9% | 90.4% | 12.5% | France |
| 2020s | 87.0% | 91.7% | 4.7% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Denmark or France?
- France, at 93.0% against 91.0% in Denmark as of 2022.
- What is the difference in access to anti-retroviral drugs, female between Denmark and France?
- 2.0%, with France ahead.
- How many years of comparable data are there for Denmark and France?
- 23 years are reported by both, from 2000 to 2022.
- How do Denmark and France rank globally for access to anti-retroviral drugs, female?
- Denmark ranks 25th and France ranks 22nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.